Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...

The following is a summary of “Comparative Outcomes of Left Main and Non-Left Main Percutaneous Coronary Intervention from ...

Wearable devices can reduce cardiovascular events and death in ischemic heart disease, according to a new meta-analysis, but ...

The primary efficacy outcome was a composite of MACE and MALE, with MACE defined as myocardial infarction, ischemic stroke, and death from cardiovascular causes, and MALE defined as urgent ...

Current guidelines regarding beta-blocker use after myocardial infarction (MI) recommend against continuation to improve outcomes ... Most patients had an index ST-segment elevation MI (63%) and ...

We aim to investigate the influence of sex on the timing and clinical outcomes of ST-segment elevation myocardial infarction (STEMI) patients using a controlled Swiss registry. Methods and results ...

Abstract: yocardial infarction (MI) stands as one of the most critical cardiac complications, occurring when blood flow to the cardiovascular system is partially or completely blocked.

Angioplasty and distal embolic protection devices (EPDs) were used in 91 (83.7%) and 58 (52.7%) procedures, respectively. tCAS led to a modified Thrombolysis in Cerebral Infarction 2b/3 in all cases.

Introduction: Interleukin-10 (IL-10) is a potent immunomodulatory cytokine widely explored as a therapeutic agent for diseases, including myocardial infarction (MI). High-dose IL-10 treatment may not ...

Medically reviewed by Rafle Fernandez, MD Stents and coronary artery bypass grafting (CABG) treat blocked arteries and ...